• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

膜转运体在药物安全性特征中的作用。

Role of membrane transporters in the safety profile of drugs.

机构信息

National University of Singapore, Clinical Research Centre, Department of Pharmacology, Singapore.

出版信息

Expert Opin Drug Metab Toxicol. 2009 Nov;5(11):1369-83. doi: 10.1517/17425250903176421.

DOI:10.1517/17425250903176421
PMID:19663740
Abstract

It has increasingly been recognized that few molecules move across the cell membrane without the assistance of transporter proteins. Large superfamilies of transporter proteins have been identified in every living cell, including microorganisms and mitochondria. This report reviews the role of transporters in physiology and pharmacology, and identifies where this may have an impact on drug efficacy and toxicity. This new understanding will require a fresh appreciation of pharmacokinetics and drug effects, as the current paradigms are based largely on the assumption that drug molecules have a reasonable unrestricted permeability across membranes. Rather than just focusing on clearance changes and central compartment pharmacokinetics, it will become increasingly necessary to examine the peripheral tissue distribution of drugs to more accurately predict drug efficacy and toxicity.

摘要

越来越多的人认识到,几乎没有分子可以在没有转运蛋白协助的情况下穿过细胞膜。在每个活细胞中,包括微生物和线粒体,都鉴定出了大量的转运蛋白超家族。本报告综述了转运蛋白在生理学和药理学中的作用,并确定了这可能对药物疗效和毒性产生影响的地方。这种新的认识将需要对药代动力学和药物作用有新的认识,因为当前的范式主要基于药物分子在穿过膜时有合理的无限制通透性的假设。与其仅仅关注清除率的变化和中央室药代动力学,检查药物在周围组织中的分布将变得越来越必要,以便更准确地预测药物的疗效和毒性。

相似文献

1
Role of membrane transporters in the safety profile of drugs.膜转运体在药物安全性特征中的作用。
Expert Opin Drug Metab Toxicol. 2009 Nov;5(11):1369-83. doi: 10.1517/17425250903176421.
2
Drug transporters in drug efficacy and toxicity.药物转运体与药物疗效和毒性。
Annu Rev Pharmacol Toxicol. 2012;52:249-73. doi: 10.1146/annurev-pharmtox-010611-134529. Epub 2011 Sep 19.
3
Genetic and/or non-genetic causes for inter-individual and inter-cellular variability in transporter protein expression: implications for understanding drug efficacy and toxicity.转运蛋白表达中个体间和细胞间变异性的遗传和/或非遗传原因:对理解药物疗效和毒性的影响。
Expert Opin Drug Metab Toxicol. 2015;11(12):1821-37. doi: 10.1517/17425255.2015.1104298. Epub 2015 Oct 21.
4
Transporters in absorption, distribution, and elimination.吸收、分布和消除中的转运体。
Chem Biodivers. 2009 Nov;6(11):1933-42. doi: 10.1002/cbdv.200900171.
5
The role of hepatic transporters in drug elimination.肝脏转运体在药物消除中的作用。
Expert Opin Drug Metab Toxicol. 2008 Apr;4(4):363-79. doi: 10.1517/17425255.4.4.363.
6
Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense.多药耐药蛋白:P-糖蛋白、多药耐药相关蛋白1、多药耐药相关蛋白2和乳腺癌耐药蛋白(ABCG2)在组织防御中的作用
Toxicol Appl Pharmacol. 2005 May 1;204(3):216-37. doi: 10.1016/j.taap.2004.10.012.
7
Transporters in drug development and clinical pharmacology.药物研发和临床药理学中的转运体。
Clin Pharmacol Ther. 2013 Jul;94(1):3-9. doi: 10.1038/clpt.2013.86.
8
Disease-Associated Changes in Drug Transporters May Impact the Pharmacokinetics and/or Toxicity of Drugs: A White Paper From the International Transporter Consortium.疾病相关的药物转运体改变可能影响药物的药代动力学和/或毒性:国际转运体联合会白皮书。
Clin Pharmacol Ther. 2018 Nov;104(5):900-915. doi: 10.1002/cpt.1115. Epub 2018 Jul 12.
9
Subcellular drug distribution: mechanisms and roles in drug efficacy, toxicity, resistance, and targeted delivery.亚细胞药物分布:在药物功效、毒性、耐药性和靶向递送中的作用机制。
Drug Metab Rev. 2018 Nov;50(4):430-447. doi: 10.1080/03602532.2018.1512614. Epub 2018 Sep 29.
10
Transporter-mediated drug delivery: recent progress and experimental approaches.转运体介导的药物递送:最新进展与实验方法
Drug Discov Today. 2004 Aug 15;9(16):712-20. doi: 10.1016/S1359-6446(04)03198-8.

引用本文的文献

1
Structure-activity relationships, ligand efficiency, and lipophilic efficiency profiles of benzophenone-type inhibitors of the multidrug transporter P-glycoprotein.苯甲酮型多药转运蛋白 P-糖蛋白抑制剂的构效关系、配体效率和脂水效率特征。
J Med Chem. 2012 Apr 12;55(7):3261-73. doi: 10.1021/jm201705f. Epub 2012 Mar 27.
2
Biomembrane models and drug-biomembrane interaction studies: Involvement in drug design and development.生物膜模型与药物-生物膜相互作用研究:在药物设计与开发中的作用
J Pharm Bioallied Sci. 2011 Jan;3(1):4-14. doi: 10.4103/0975-7406.76461.